Figure 2. Peribronchial and parenchymal infiltrates on chest X-ray
The patient was given a fixed-dose combination of antituberculosis therapy consisting of isoniazid (225 mg), rifampicin (450 mg), ethambutol (825 mg), and pyrazinamide (1200 mg). The follow up showed significant improvement.